Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.44 USD | +1.01% | +1.27% | +10.38% |
Apr. 03 | KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. | CI |
Mar. 26 | Bluebird bio to Restate Financial Statements; Shares Fall | MT |
Financials (USD)
Sales 2024 * | 504M | Sales 2025 * | 536M | Capitalization | 2.93B |
---|---|---|---|---|---|
Net income 2024 * | 326M | Net income 2025 * | 336M | EV / Sales 2024 * | 5.81 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.46 x |
P/E ratio 2024 * |
8.92
x | P/E ratio 2025 * |
9.14
x | Employees | - |
Yield 2024 * |
8.77% | Yield 2025 * |
9.06% | Free-Float | 98.12% |
Latest transcript on Hercules Capital, Inc.
1 day | +0.50% | ||
1 week | -0.87% | ||
Current month | -1.08% | ||
1 month | +1.22% | ||
3 months | +7.80% | ||
6 months | +14.56% | ||
Current year | +9.48% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Bluestein
CEO | Chief Executive Officer | 45 | 10-11-16 |
Seth H. Meyer
DFI | Director of Finance/CFO | 55 | 19-03-03 |
Kiersten Botelho
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gayle Crowell
BRD | Director/Board Member | 73 | 19-02-03 |
Chairman | 71 | 06-02-28 | |
Director/Board Member | 61 | 23-09-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 18.41 | +0.89% | 479 770 |
24-04-18 | 18.25 | +0.50% | 589,984 |
24-04-17 | 18.16 | +0.94% | 726,464 |
24-04-16 | 17.99 | +0.17% | 1,225,085 |
24-04-15 | 17.96 | -1.16% | 745,409 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.48% | 2.93B | |
+31.41% | 12.02B | |
+1.42% | 1.4B | |
-8.46% | 1.22B | |
-1.95% | 597M | |
+50.00% | 624M | |
-20.39% | 518M | |
+35.40% | 493M | |
-4.17% | 492M | |
+3.90% | 304M |
- Stock Market
- Equities
- HTGC Stock